MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas
Nayyar, Naema, White, Michael D., Gill, Corey M., Lastrapes, Matthew, Bertalan, Mia, Kaplan, Alexander, D'Andrea, Megan R., Bihun, Ivanna, Kaneb, Andrew, Dietrich, Jorg, Ferry, Judith A., Martinez-Lage, Maria, Giobbie-Hurder, Anita, Borger, Darrell R., Rodriguez, Fausto J., Frosch, Matthew P., Batchelor, Emily, Hoang, Kaitlin, Kuter, Benjamin, Fortin, Sarah, Holdhoff, Matthias, Cahill, Daniel P., Carter, Scott, Brastianos, Priscilla K., Batchelor, Tracy T.
Published in Blood advances (12.02.2019)
Published in Blood advances (12.02.2019)
Get full text
Journal Article
Abstract LB063: Anti-tumor activity in preclinical models utilizing a conditional bispecific redirected activation molecule (COBRA) targeting Her2
Stringer, Bradley, Chouitar, Johara, Cerbone, Jacqualine, Fortin, Sarah, Ainbinder, Alina, Kysilovsky, Cassie, Scott, Brittany, Banerjee, Antara
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Published in Cancer research (Chicago, Ill.) (05.04.2024)
Get full text
Journal Article